Clinical Trial Update: WEE1 Inhibitor with Cisplatin and Radiotherapy: a Trial in Head and Neck Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a WEE1 inhibitor in combination with cisplatin and radiotherapy for head and neck cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypopharyngeal Cancer
• Laryngeal Cancer
• Oral Cavity Squamous Cell Carcinoma

Drugs mentioned

• Adavosertib (adavosertib)
• CISPLATIN (cisplatin)

Snippet

Sponsor: University of Birmingham | Conditions: Hypopharynx Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma | Phase 1 | Status: COMPLETED